A phase 3b study of venetoclax and azacitidine or decitabine in an outpatient setting in patients with acute myeloid leukemia.
Saved in:
| Title: | A phase 3b study of venetoclax and azacitidine or decitabine in an outpatient setting in patients with acute myeloid leukemia. |
|---|---|
| Authors: | Manda S; Arizona Oncology, The US Oncology Network, Tucson, Arizona, USA., Anz BM 3rd; Tennessee Oncology, Chattanooga, Tennessee, USA., Benton C; Rocky Mountain Cancer Centers, The US Oncology Network, Englewood, Colorado, USA., Broun ER; Oncology Hematology Care Inc, Cincinnati, Ohio, USA., Yimer HA; Texas Oncology/USON, Tyler, Texas, USA., Renshaw JS; Texas Oncology - San Antonio Medical Center, The US Oncology Network, San Antonio, Texas, USA., Geils G Jr; Charleston Oncology, Charleston, South Carolina, USA., Berdeja J; Sarah Cannon Research Institute and Tennessee Oncology, Nashville, Tennessee, USA., Cruz J; Methodist Physicians Texas Transplant Specialists, San Antonio, Texas, USA., Melear JM; Texas Oncology - Austin Midtown, The US Oncology Network, Austin, Texas, USA., Fanning S; Prisma Health Cancer Institute, Greenville, South Carolina, USA., Fletcher L; Willamette Valley Cancer Institute and US Oncology Research Center, Eugene, Oregon, USA., Li Y; AbbVie, Inc, North Chicago, Illinois, USA., Duan Y; AbbVie, Inc, North Chicago, Illinois, USA., Werner ME; AbbVie, Inc, North Chicago, Illinois, USA., Potluri J; AbbVie, Inc, North Chicago, Illinois, USA., Pai MV; AbbVie, Inc, North Chicago, Illinois, USA., Donnellan WB; Sarah Cannon Research Institute and Tennessee Oncology, Nashville, Tennessee, USA. |
| Source: | Hematological oncology [Hematol Oncol] 2024 May; Vol. 42 (3), pp. e3274. |
| Publication Type: | Journal Article; Clinical Trial, Phase III; Multicenter Study |
| Journal Info: | Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 8307268 Publication Model: Print Cited Medium: Internet ISSN: 1099-1069 (Electronic) Linking ISSN: 02780232 NLM ISO Abbreviation: Hematol Oncol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 38711253 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: A phase 3b study of venetoclax and azacitidine or decitabine in an outpatient setting in patients with acute myeloid leukemia. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Manda+S%22">Manda S</searchLink>; Arizona Oncology, The US Oncology Network, Tucson, Arizona, USA.<br /><searchLink fieldCode="AU" term="%22Anz+BM+3rd%22">Anz BM 3rd</searchLink>; Tennessee Oncology, Chattanooga, Tennessee, USA.<br /><searchLink fieldCode="AU" term="%22Benton+C%22">Benton C</searchLink>; Rocky Mountain Cancer Centers, The US Oncology Network, Englewood, Colorado, USA.<br /><searchLink fieldCode="AU" term="%22Broun+ER%22">Broun ER</searchLink>; Oncology Hematology Care Inc, Cincinnati, Ohio, USA.<br /><searchLink fieldCode="AU" term="%22Yimer+HA%22">Yimer HA</searchLink>; Texas Oncology/USON, Tyler, Texas, USA.<br /><searchLink fieldCode="AU" term="%22Renshaw+JS%22">Renshaw JS</searchLink>; Texas Oncology - San Antonio Medical Center, The US Oncology Network, San Antonio, Texas, USA.<br /><searchLink fieldCode="AU" term="%22Geils+G+Jr%22">Geils G Jr</searchLink>; Charleston Oncology, Charleston, South Carolina, USA.<br /><searchLink fieldCode="AU" term="%22Berdeja+J%22">Berdeja J</searchLink>; Sarah Cannon Research Institute and Tennessee Oncology, Nashville, Tennessee, USA.<br /><searchLink fieldCode="AU" term="%22Cruz+J%22">Cruz J</searchLink>; Methodist Physicians Texas Transplant Specialists, San Antonio, Texas, USA.<br /><searchLink fieldCode="AU" term="%22Melear+JM%22">Melear JM</searchLink>; Texas Oncology - Austin Midtown, The US Oncology Network, Austin, Texas, USA.<br /><searchLink fieldCode="AU" term="%22Fanning+S%22">Fanning S</searchLink>; Prisma Health Cancer Institute, Greenville, South Carolina, USA.<br /><searchLink fieldCode="AU" term="%22Fletcher+L%22">Fletcher L</searchLink>; Willamette Valley Cancer Institute and US Oncology Research Center, Eugene, Oregon, USA.<br /><searchLink fieldCode="AU" term="%22Li+Y%22">Li Y</searchLink>; AbbVie, Inc, North Chicago, Illinois, USA.<br /><searchLink fieldCode="AU" term="%22Duan+Y%22">Duan Y</searchLink>; AbbVie, Inc, North Chicago, Illinois, USA.<br /><searchLink fieldCode="AU" term="%22Werner+ME%22">Werner ME</searchLink>; AbbVie, Inc, North Chicago, Illinois, USA.<br /><searchLink fieldCode="AU" term="%22Potluri+J%22">Potluri J</searchLink>; AbbVie, Inc, North Chicago, Illinois, USA.<br /><searchLink fieldCode="AU" term="%22Pai+MV%22">Pai MV</searchLink>; AbbVie, Inc, North Chicago, Illinois, USA.<br /><searchLink fieldCode="AU" term="%22Donnellan+WB%22">Donnellan WB</searchLink>; Sarah Cannon Research Institute and Tennessee Oncology, Nashville, Tennessee, USA. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%228307268%22">Hematological oncology</searchLink> [Hematol Oncol] 2024 May; Vol. 42 (3), pp. e3274. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Clinical Trial, Phase III; Multicenter Study – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Wiley-Blackwell%22">Wiley-Blackwell </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>8307268 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1099-1069 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2202780232%22">02780232 </searchLink><i>NLM ISO Abbreviation: </i>Hematol Oncol <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=38711253 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1002/hon.3274 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: e3274 Titles: – TitleFull: A phase 3b study of venetoclax and azacitidine or decitabine in an outpatient setting in patients with acute myeloid leukemia. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Manda S – PersonEntity: Name: NameFull: Anz BM 3rd – PersonEntity: Name: NameFull: Benton C – PersonEntity: Name: NameFull: Broun ER – PersonEntity: Name: NameFull: Yimer HA – PersonEntity: Name: NameFull: Renshaw JS – PersonEntity: Name: NameFull: Geils G Jr – PersonEntity: Name: NameFull: Berdeja J – PersonEntity: Name: NameFull: Cruz J – PersonEntity: Name: NameFull: Melear JM – PersonEntity: Name: NameFull: Fanning S – PersonEntity: Name: NameFull: Fletcher L – PersonEntity: Name: NameFull: Li Y – PersonEntity: Name: NameFull: Duan Y – PersonEntity: Name: NameFull: Werner ME – PersonEntity: Name: NameFull: Potluri J – PersonEntity: Name: NameFull: Pai MV – PersonEntity: Name: NameFull: Donnellan WB IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 05 Text: 2024 May Type: published Y: 2024 Identifiers: – Type: issn-electronic Value: 1099-1069 Numbering: – Type: volume Value: 42 – Type: issue Value: 3 Titles: – TitleFull: Hematological oncology Type: main |
| ResultId | 1 |